-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VIO-01 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VIO-01 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VIO-01 in Solid Tumor Drug Details: VIO-01 (formerly OX425) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VIO-01 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VIO-01 in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VIO-01 in Metastatic Breast Cancer Drug Details: VIO-01 (formerly OX425)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VIO-01 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VIO-01 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VIO-01 in Metastatic Ovarian Cancer Drug Details: VIO-01 (formerly OX425)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VIO-01 in Metastatic Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VIO-01 in Metastatic Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VIO-01 in Metastatic Prostate Cancer Drug Details: VIO-01 (formerly OX425)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VIO-01 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VIO-01 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VIO-01 in Triple-Negative Breast Cancer (TNBC) Drug Details: VIO-01...
-
Product Insights
Real Treuhand Imob – Vio Plaza Mixed-Use Complex – Vienna
Equip yourself with the essential tools needed to make informed and profitable decisions with our Real Treuhand Imob - Vio Plaza Mixed-Use Complex - Vienna report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Thematic Analysis
Femtech (Women’s Health) – Thematic Intelligence
Femtech Market Analysis Report Overview Femtech refers to a wide range of technologies and products that aim to address women's health issues, including menstrual health, reproductive health, sexual health, maternal health, and menopause. It includes mobile health (mHealth), telemedicine platforms, wearable devices, diagnostic tools, and even drugs for treating conditions that disproportionately impact women. The Femtech industry is still relatively young, however, there is a growing awareness and need for innovation to improve unmet needs in women's health. Femtech research...
-
Sector Analysis
China Contract Manufacturing Market Outlook – Trends, Ambitions, Key Players, Investment and Value Chain
There is an increasing reliance on contract manufacturing and development services due to the growing regulatory complexity surrounding drug production and development. China has been focusing on establishing volume and enhancing capabilities for innovative high-value drug production. This will enable the Chinese pharma manufacturers to compete with US and European equivalents in terms of obtaining contracts for lucrative treatments such as gene and cell therapies. China is also upgrading its manufacturing capabilities, boosting innovation, and strengthening its position in a...
-
Track & Monitor
Innovation in Healthcare: Radiotherapy Techniques
Innovations in healthcare industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in healthcare industry. Using patent data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating or...
-
Sector Analysis
United Kingdom General Surgery Market Outlook to 2025 – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices and Others
GlobalData’s “United Kingdom General Surgery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United Kingdom General Surgery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices, Bariatric Surgery Devices, Biopsy Devices, Bronchoscopes, Chest Drainage Catheters and Units, Colonoscopes, Cystoscopes, Duodenoscopes, Embolization Particles, Endoscopy Fluid Management Systems, Endoscopy Visualization Systems and Components, Esophagoscopes & Gastroscopes, Gynecological Devices,...